The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP [4]

Annals of Oncology

Volumn 17, Issue 1, 2006, Pages 176-177

  Dawson, M A ^a   Mariani, J ^a   Taylor, A ^a   Koulouris, G ^a   Avery, S ^a  

^a The Alfred ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GROWTH FACTOR; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE SULFATE;

AGED; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEART CANCER; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LUNG ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK REDUCTION; SENSITIVITY ANALYSIS; TUMOR BIOPSY; TUMOR REGRESSION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HEART NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; PREDNISONE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VINCRISTINE;

EID: 29844444318     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj005     Document Type: Letter

References (5)

1. Ceresoli GL, Ferreri AJ, Bucci E et al. Primary cardiac lymphoma in immunocompetent patients: Diagnostic and therapeutic management. Cancer 1997; 80: 1497-1506.
2. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
3. Molajo AO, McWilliam L, Ward C, Rahman A. Cardiac lymphoma: An unusual case of myocardial perforation - clinical, echocardiographic, haemodynamic and pathological features. Eur Heart J 1987; 8: 549-552.
4. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
5. Pfreundschuh M, Trumper L, Kloess M et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood 2004; 104: 634-641.